Pain Management Drugs and Devices - Global Market Outlook (2017-2023)

  • ID: 4480630
  • Report
  • Region: Global
  • 198 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astrazeneca Plc
  • DJO Global Inc.
  • Endo International
  • Grunenthal Gmbh
  • Medtronic
  • MORE
According to the publisher, the Global Pain Management Drugs and Devices Market is accounted for $41.73 billion in 2016 and is expected to reach $61.52 billion by 2023 growing at a CAGR of 5.7% during the forecast period. Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation. Neuromodulation devices are used by the application of electrodes the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a power source and pulse generato r, which generates required electrical impulses. North America is anticipated to hold the largest market share due the rising incidence of chronic diseases, increasing government support, growing middle-class population and disposable income levels in this region.

Some of the key players in the Pain Management Drugs and Devices Market include Abbott Laborato ries, End-International, Abbvie, DJ-Global Inc., Johnson & Johnson, Novartis International AG, Grunenthal Gmbh, ELI Lilly & Co, Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Astrazeneca Plc, Purdue Pharma LP, Glaxosmithkline, Medtronic and Bosto n Scientific Corp.

Device Types Covered:
  • Neuromodulation Devices
  • Analgesic Infusion Pumps
  • Ablation Devices
  • Electrical stimulation devices
Drug Classes Covered:
  • Non-Narcotic Analgesics
  • Narcotic Pain Management
  • Opioids
  • Antidepressent
  • Anesthetics
  • NSAIDS
  • Anticovulsants
  • Anti-Migraine Agents
  • Other Drug Classes
Applications Covered:
  • General Pain
  • Dental Pain
  • HIV/AIDS Pain
  • Migraine Pain
  • Orthopedic/Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Fibromyalgia Pain
  • Surgical Pain
  • Other Applications
Indications Covered:
  • Arthritic Pain
  • Chronic back pain
Mode of Purchases Covered:
  • Over-the-counter Devices
  • Over-the-counter Devices
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

A Datapack/Market Engineering Excel Sheet is provided for free with the purchase of the Report format Enterprisewide.  A Datapack/Market Engineering Excel Sheet is provided for free with the purchase of the Report format Enterprisewide. 
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astrazeneca Plc
  • DJO Global Inc.
  • Endo International
  • Grunenthal Gmbh
  • Medtronic
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pain Management Drugs and Devices Market, By Device Type
5.1 Introduction
5.2 Neuromodulation Devices
5.2.1 Spinal Cord Stimulation (SCS) Devices
5.2.2 Sacral Nerve Stimulation Devices
5.2.3 Vagus Nerve Stimulation Devices
5.2.4 Deep Brain Stimulation Devices
5.3 Analgesic Infusion Pumps
5.3.1 Intrathecal Infusion Pumps
5.3.2 External Infusion Pumps
5.4 Ablation Devices
5.4.1 Radiofrequency Ablation Devices
5.4.2 Cryoablation Devices
5.5 Electrical stimulation devices
5.5.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
5.5.2 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
5.5.3 Other Electrical Stimulation Devices

6 Global Pain Management Drugs and Devices Market, By Drug Classes
6.1 Introduction
6.2 Non-Narcotic Analgesics
6.3 Narcotic Pain Management
6.4 Opioids
6.5 Antidepressent
6.6 Anesthetics
6.7 NSAIDS
6.8 Anticovulsants
6.9 Anti-Migraine Agents
6.10 Other Drug Classes

7 Global Pain Management Drugs and Devices Market, By Application
7.1 Introduction
7.2 General Pain
7.3 Dental Pain
7.4 HIV/AIDS Pain
7.5 Migraine Pain
7.6 Orthopedic/Musculoskeletal Pain
7.7 Neuropathic Pain
7.8 Cancer Pain
7.9 Fibromyalgia Pain
7.10 Surgical Pain
7.11 Other Applications

8 Global Pain Management Drugs and Devices Market, By Indication
8.1 Introduction
8.2 Arthritic Pain
8.3 Chronic back pain

9 Global Pain Management Drugs and Devices Market, By Mode of Purchase
9.1 Introduction
9.2 Over-the-counter Devices
9.3 Prescription-based Devices

10 Global Pain Management Drugs and Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbott Laboratories
12.2 Endo International
12.3 Abbvie
12.4 DJO Global Inc.
12.5 Johnson & Johnson
12.6 Novartis International AG
12.7 Grunenthal Gmbh
12.8 ELI Lilly & Co.
12.9 Hisamitsu Pharmaceutical Co. Inc.
12.10 Pfizer Inc.
12.11 Astrazeneca Plc
12.12 Purdue Pharma LP
12.13 Glaxosmithkline
12.14 Medtronic
12.15 Boston Scientific Corp

List of Tables
Table 1 Global Pain Management Drugs and Devices Market Outlook, By Region (2014-2023) (US $MN)
Table 2 Global Pain Management Drugs and Devices Market Outlook, By Device Type (2014-2023) (US $MN)
Table 3 Global Pain Management Drugs and Devices Market Outlook, By Neuromodulation Devices (2014-2023) (US $MN)
Table 4 Global Pain Management Drugs and Devices Market Outlook, By Spinal Cord Stimulation (SCS) Devices (2014-2023) (US $MN)
Table 5 Global Pain Management Drugs and Devices Market Outlook, By Sacral Nerve Stimulation Devices (2014-2023) (US $MN)
Table 6 Global Pain Management Drugs and Devices Market Outlook, By Vagus Nerve Stimulation Devices (2014-2023) (US $MN)
Table 7 Global Pain Management Drugs and Devices Market Outlook, By Deep Brain Stimulation Devices (2014-2023) (US $MN)
Table 8 Global Pain Management Drugs and Devices Market Outlook, By Analgesic Infusion Pumps (2014-2023) (US $MN)
Table 9 Global Pain Management Drugs and Devices Market Outlook, By Intrathecal Infusion Pumps (2014-2023) (US $MN)
Table 10 Global Pain Management Drugs and Devices Market Outlook, By External Infusion Pumps (2014-2023) (US $MN)
Table 11 Global Pain Management Drugs and Devices Market Outlook, By Ablation Devices (2014-2023) (US $MN)
Table 12 Global Pain Management Drugs and Devices Market Outlook, By Radiofrequency Ablation Devices (2014-2023) (US $MN)
Table 13 Global Pain Management Drugs and Devices Market Outlook, By Cryoablation Devices (2014-2023) (US $MN)
Table 14 Global Pain Management Drugs and Devices Market Outlook, By Electrical stimulation devices (2014-2023) (US $MN)
Table 15 Global Pain Management Drugs and Devices Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2014-2023) (US $MN)
Table 16 Global Pain Management Drugs and Devices Market Outlook, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2014-2023) (US $MN)
Table 17 Global Pain Management Drugs and Devices Market Outlook, By Other Electrical Stimulation Devices (2014-2023) (US $MN)
Table 18 Global Pain Management Drugs and Devices Market Outlook, By Drug Classes (2014-2023) (US $MN)
Table 19 Global Pain Management Drugs and Devices Market Outlook, By Non-Narcotic Analgesics (2014-2023) (US $MN)
Table 20 Global Pain Management Drugs and Devices Market Outlook, By Narcotic Pain Management (2014-2023) (US $MN)
Table 21 Global Pain Management Drugs and Devices Market Outlook, By Opioids (2014-2023) (US $MN)
Table 22 Global Pain Management Drugs and Devices Market Outlook, By Antidepressent (2014-2023) (US $MN)
Table 23 Global Pain Management Drugs and Devices Market Outlook, By Anesthetics (2014-2023) (US $MN)
Table 24 Global Pain Management Drugs and Devices Market Outlook, By NSAIDS (2014-2023) (US $MN)
Table 25 Global Pain Management Drugs and Devices Market Outlook, By Anticovulsants (2014-2023) (US $MN)
Table 26 Global Pain Management Drugs and Devices Market Outlook, By Anti-Migraine Agents (2014-2023) (US $MN)
Table 27 Global Pain Management Drugs and Devices Market Outlook, By Other Drugs Classes (2014-2023) (US $MN)
Table 28 Global Pain Management Drugs and Devices Market Outlook, By Application (2014-2023) (US $MN)
Table 29 Global Pain Management Drugs and Devices Market Outlook, By General Pain (2014-2023) (US $MN)
Table 30 Global Pain Management Drugs and Devices Market Outlook, By Dental Pain (2014-2023) (US $MN)
Table 31 Global Pain Management Drugs and Devices Market Outlook, By HIV/AIDS Pain (2014-2023) (US $MN)
Table 32 Global Pain Management Drugs and Devices Market Outlook, By Migraine Pain (2014-2023) (US $MN)
Table 33 Global Pain Management Drugs and Devices Market Outlook, By Orthopedic/Musculoskeletal Pain (2014-2023) (US $MN)
Table 34 Global Pain Management Drugs and Devices Market Outlook, By Neuropathic Pain (2014-2023) (US $MN)
Table 35 Global Pain Management Drugs and Devices Market Outlook, By Cancer Pain (2014-2023) (US $MN)
Table 36 Global Pain Management Drugs and Devices Market Outlook, By Fibromyalgia Pain (2014-2023) (US $MN)
Table 37 Global Pain Management Drugs and Devices Market Outlook, By Surgical Pain (2014-2023) (US $MN)
Table 38 Global Pain Management Drugs and Devices Market Outlook, By Other Applications (2014-2023) (US $MN)
Table 39 Global Pain Management Drugs and Devices Market Outlook, By Indication (2014-2023) (US $MN)
Table 40 Global Pain Management Drugs and Devices Market Outlook, By Arthritic Pain (2014-2023) (US $MN)
Table 41 Global Pain Management Drugs and Devices Market Outlook, By Chronic back pain (2014-2023) (US $MN)
Table 42 Global Pain Management Drugs and Devices Market Outlook, By Mode of Purchase (2014-2023) (US $MN)
Table 43 Global Pain Management Drugs and Devices Market Outlook, By Over-the-Counter Devices (2014-2023) (US $MN)
Table 44 Global Pain Management Drugs and Devices Market Outlook, By Prescription-Based Devices (2014-2023) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Abbott Laboratories
Endo International
Abbvie
DJO Global Inc.
Johnson & Johnson
Novartis International AG
Grunenthal Gmbh
ELI Lilly & Co.
Hisamitsu Pharmaceutical Co. Inc.
Pfizer Inc.
Astrazeneca Plc
Purdue Pharma LP
Glaxosmithkline
Medtronic
Boston Scientific Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll